Thyrotropin-releasing hormone stimulates phosphorylation of the epidermal growth factor receptor in GH3 pituitary cells

Molecular Endocrinology

Volumn 14, Issue 9, 2000, Pages 1328-1337

  Wang, Ying Hong ^a   Jue, Shall F ^a   Maurer, Richard A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE; PROTIRELIN RECEPTOR;

ARTICLE; ENZYME ACTIVATION; ENZYME INHIBITION; HYPOPHYSIS CELL; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0033755279     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.14.9.0512     Document Type: Article

References (55)

1. Molecular and cellular biology of thyrotropin-releasing hormone receptors
2. 3 rat pituitary cells
3. Thyrotropin-releasing hormone action: Mechanism of calcium-mediated stimulation of prolactin secretion
4. Thyrotropin-releasing hormone (TRH) stimulates biphasic elevation of cytoplasmic free calcium in GH3 cells. Further evidence that TRH mobilizes cellular and extracellular Ca2+
5. Thyrotropin-releasing hormone stimulates MAP kinase activity in GH3 cells by divergent pathways. Evidence of a role for early tyrosine phosphorylation
6. A role for the mitogen-activated protein kinase in mediating the ability of thyrotropin-releasing hormone to stimulate the prolactin promoter
7. Growth factor signaling by receptor tyrosine kinases
8. Monoclonal antibodies against epidermal growth factor receptor induce prolactin synthesis in cultured rat pituitary cells
9. Epidermal growth factor and expression of specific genes: Effects on cultured rat pituitary cells are dissociable from the mitogenic response
10. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP
11. Receptor-tyrosine-kinase- and Gβγ-mediated MAP kinase activation by a common signaling pathway
12. Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gβγ subunit-mediated activation of mitogen-activated protein kinases
13. Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. Convergence of G1 and G(q)-mediated pathways on calcium/calmodulin Pyk2, and Src kinase
14. Gβγ subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation
15. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase
16. Tyrosine kinase inhibiton: An approach to drug development
17. Identification of tyrosine 67 in bovine brain myelin basic protein as a specific phosphorylation site for thymus p561ck
18. Integrins induce activation of EGF receptor: Role in MAP kinase induction and adhesion-dependent cell survival
19. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases
20. Epidermal growth factor regulated p21(ras) through the formation of complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor
21. A novel transforming protein (SHC) with an SH3 domain is implicated in mitogenic signal transduction
22. All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired
23. The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: From orphanhood to multiple stromal ligands
24. Intermolecular association of the p185(neu) protein and EGF receptor modulates EGF receptor function
25. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions
26. Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts
27. Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling
28. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: Implications for breast cancer
29. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C
30. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and Fyn T-dependent T cell activation
31. Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants
32. Tyrosine kinases in activation of the MAP kinase cascade by G-protein-coupled receptors
33. 2+-induced regulation of ion channel and MAP kinase functions
34. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation
35. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors
36. Epidermal growth factor receptor tyrosine kinase mediates Ras activation by gonadotropin-releasing hormone
37. ErB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
38. Differential endocytic routing of homo and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers
39. A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway
40. Platelet-derived growth factor mimics phorbol diester action on epidermal growth factor receptor phosphorylation at threonine-654
41. Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane
42. Release of a phorbol ester-induced mitogenic block by mutation at Thr-654 of the epidermal growth factor receptor
43. Tumor promoters block tyrosine-specific phosphorylation of the epidermal growth factor receptor
44. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents
45. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF
46. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site
47. A metalloprotease-disintegrin, MDC9/meltrin-γ/ADAM9 and PKCδ are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor
48. 3 cells by thyrotropin-releasing hormone
49. Epidermal growth factor rapidly stimulates prolactin gene transcription
50. Polypeptide hormone regulation of gene expression. Thyrotropin-releasing hormone rapidly stimulates both transcription of the prolactin gene and the phosphorylation of a specific nuclear protein
51. Thyrotropin-releasing hormone and epidermal growth factor induce human prolactin expression via identical multiple cis elements
52. Firefly luciferase gene: Structure and expression in mammalian cells
53. 2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity
54. A role for mitogen-activated protein kinase in mediating activation of the glycoprotein hormone α-subunit gonadotropin-releasing hormone
55. The distal enhancer region of the rat prolactin gene contains elements conferring response to multiple hormones